Patent · US Active

Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin

US7928095B2 · kind B2 · utility

1Cited by
31References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 8, 2008
Grant dateApr 19, 2011
Priority date
Expiry dateSep 18, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating a resistant or refractory cancer in a mammal includes administering an effective amount of a compound ofto the mammal. In preferred aspects, the cancer is resistant or refractory to CPT-11 or CPT therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.